|
1
|
Ottaviani G and Jaffe N: The epidemiology
of osteosarcoma. Cancer Treat Res. 152:3–13. 2009. View Article : Google Scholar
|
|
2
|
Mirabello L, Troisi RJ and Savage SA:
Osteosarcoma incidence and survival rates from 1973 to 2004: Data
from the Surveillance, epidemiology, and end results program.
Cancer. 115:1531–1543. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Huh WW, Holsinger FC, Levy A, Palla FS and
Anderson PM: Osteosarcoma of the jaw in children and young adults.
Head Neck. 34:981–984. 2012. View Article : Google Scholar
|
|
4
|
Mohseny AB, Machado I, Cai Y, Schaefer KL,
Serra M, Hogendoorn PC, Llombart-Bosch A and Cleton-Jansen AM:
Functional characterization of osteosarcoma cell lines provides
representative models to study the human disease. Lab Invest.
91:1195–1205. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hsieh YS, Chu SC, Yang SF, Chen PN, Liu YC
and Lu KH: Silibinin suppresses human osteosarcoma MG-63 cell
invasion by inhibiting the ERK-dependent c-Jun/AP-1 induction of
MMP-2. Carcinogenesis. 28:977–987. 2007. View Article : Google Scholar
|
|
6
|
Lu KH, Yang HW, Su CW, Lue KH, Yang SF and
Hsieh YS: Phyllanthus urinaria suppresses human osteosarcoma cell
invasion and migration by transcriptionally inhibiting u-PA via ERK
and Akt signaling pathways. Food Chem Toxicol. 52:193–199. 2013.
View Article : Google Scholar
|
|
7
|
Stallings-Mann M and Radisky D: Matrix
metalloproteinase-induced malignancy in mammary epithelial cells.
Cells Tissues Organs. 185:104–110. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kessenbrock K, Plaks V and Werb Z: Matrix
metalloproteinases: Regulators of the tumor microenvironment. Cell.
141:52–67. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liotta LA and Stetler-Stevenson WG:
Metalloproteinases and cancer invasion. Semin Cancer Biol.
1:99–106. 1990.PubMed/NCBI
|
|
10
|
Himelstein BP, Canete-Soler R, Bernhard
EJ, Dilks DW and Muschel RJ: Metalloproteinases in tumor
progression: The contribution of MMP-9. Invasion Metastasis.
14:246–258. 1994.PubMed/NCBI
|
|
11
|
Kim BS, Park JY, Kang HJ, Kim HJ and Lee
J: Fucoidan/FGF-2 induces angiogenesis through JNK- and
p38-mediated activation of AKT/MMP-2 signalling. Biochem Biophys
Res Commun. 450:1333–1338. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jin YJ, Park I, Hong IK, Byun HJ, Choi J,
Kim YM and Lee H: Fibronectin and vitronectin induce AP-1-mediated
matrix metalloproteinase-9 expression through integrin
α(5)β(1)/α(v) β(3)-dependent Akt, ERK and JNK signaling pathways in
human umbilical vein endothelial cells. Cell Signal. 23:125–134.
2011. View Article : Google Scholar
|
|
13
|
Gordaliza M: Natural products as leads to
anticancer drugs. Clin Transl Oncol. 9:767–776. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang P, Yang HL, Yang YJ, Wang L and Lee
SC: Overcome cancer cell drug resistance using natural products.
Evid Based Complement Alternat Med. 2015:7671362015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li Q, Xiao M, Guo L, Wang L, Tang L, Xu Y,
Yan F and Chen F: Genetic diversity and genetic structure of an
endangered species, Trillium tschonoskii. Biochem Genet.
43:445–458. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li Y, Sun Y, Fan L, Zhang F, Meng J, Han
J, Guo X, Zhang D, Zhang R, Yue Z, et al: Paris saponin VII
inhibits growth of colorectal cancer cells through Ras signaling
pathway. Biochem Pharmacol. 88:150–157. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li Y, Liu C, Xiao D, Han J, Yue Z, Sun Y,
Fan L, Zhang F, Meng J, Zhang R, et al: Trillium tschonoskii
steroidal saponins suppress the growth of colorectal Cancer cells
in vitro and in vivo. J Ethnopharmacol. 168:136–145. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fan L, Li Y, Sun Y, Yue Z, Meng J, Zhang
X, Zhang R, Zhang D, Zhang F and Mei Q: Paris saponin VII inhibits
metastasis by modulating matrix metalloproteinases in colorectal
cancer cells. Mol Med Rep. 11:705–711. 2015.
|
|
19
|
Zhang W, Zhang D, Ma X, Liu Z, Li F and Wu
D: Paris saponin VII suppressed the growth of human cervical cancer
Hela cells. Eur J Med Res. 19:412014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li Y, Fan L, Sun Y, Miao X, Zhang F, Meng
J, Han J, Zhang D, Zhang R, Yue Z and Mei Q: Paris saponin VII from
trillium tschonoskii reverses multidrug resistance of
adriamycin-resistant MCF-7/ADR cells via P-glycoprotein inhibition
and apoptosis augmentation. J Ethnopharmacol. 154:728–734. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fan L, Li Y, Sun Y, Han J, Yue Z, Meng J,
Zhang X, Zhang F and Mei Q: Paris Saponin VII inhibits the
migration and invasion in human A549 lung cancer cells. Phytother
Res. Jun 24–2015.Epub ahead of print. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real time quantitative PCR and
2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar
|
|
23
|
Gialeli C, Theocharis AD and Karamanos NK:
Roles of matrix metalloproteinases in cancer progression and their
pharmacological targeting. FEBS J. 278:16–27. 2011. View Article : Google Scholar
|
|
24
|
Kallakury BV, Karikehalli S, Haholu A,
Sheehan CE, Azumi N and Ross JS: Increased expression of matrix
metalloproteinases 2 and 9 and tissue inhibitors of
metalloproteinases 1 and 2 correlate with poor prognostic variables
in renal cell carcinoma. Clin Cancer Res. 7:3113–3119.
2001.PubMed/NCBI
|
|
25
|
Rajoria S, Suriano R, Wilson YL, Schantz
SP, Moscatello A, Geliebter J and Tiwari RK: 3,3′-diindolylmethane
inhibits migration and invasion of human cancer cells through
combined suppression of ERK and AKT pathways. Oncol Rep.
25:491–497. 2011.
|
|
26
|
Surh YJ: Cancer chemoprevention with
dietary phytochemicals. Nat Rev Cancer. 3:768–780. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Thomasset SC, Berry DP, Garcea G, Marczylo
T, Steward WP and Gescher AJ: Dietary polyphenolic
phytochemicals-promising cancer chemopreventive agents in humans? A
review of their clinical properties. Int J Cancer. 120:451–458.
2007. View Article : Google Scholar
|
|
28
|
Poudel B and Kim DK, Ki HH, Kwon YB, Lee
YM and Kim DK: Downregulation of ERK signaling impairs U2OS
osteosarcoma cell migration in collagen matrix by suppressing MMP9
production. Oncol Letters. 7:215–218. 2014.
|
|
29
|
Liu F and Zhang Q: Questions about XY Wen
et al. Entitled 'Matrix metalloproteinase 2 expression and survival
of patients with osteosarcoma: A meta-analysis'. Tumour Biol.
36:557–558. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wen X, Liu H, Yu K and Liu Y: Matrix
metalloproteinase 2 expression and survival of patients with
osteosarcoma: A meta-analysis. Tumour Biol. 35:845–848. 2014.
View Article : Google Scholar
|
|
31
|
Thompson N and Lyons J: Recent progress in
targeting the Raf/MEK/ERK pathway with inhibitors in cancer drug
discovery. Curr Opin Pharmacol. 5:350–356. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang X, Wang X, Wu T, Li B, Liu T, Wang
R, Liu Q, Liu Z, Gong Y and Shao C: Isoliensinine induces apoptosis
in triple-negative human breast cancer cells through ROS generation
and p38 MAPK/JNK activation. Sci Rep. 5:125792015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Xia P, Zhang R and Ge G: C/EBPβ mediates
TNF-α-induced cancer cell migration by inducing MMP expression
dependent on p38 MAPK. J Cell Biochem. 116:2766–2777. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gupta J and Nebreda AR: Roles of p38α
mitogen-activated protein kinase in mouse models of inflammatory
diseases and cancer. FEBS J. 282:1841–1857. 2015. View Article : Google Scholar : PubMed/NCBI
|
